[Gastrointestinal Cancers Symposium 2015: New analysis from PEAK study: Early, deep and sustained tumor shrinkage by panitumumab].

Source :: Oncology research and treatment [Oncol Res Treat] 2015; Vol. 38 (5), pp. 258-9.
Publication Year :: 2015

Subjects :: Colorectal Neoplasms metabolism
Colorectal Neoplasms secondary
ErbB Receptors metabolism
Genes, ras physiology
Humans
Neoplasm Metastasis drug therapy
Panitumumab
Antibodies, Monoclonal therapeutic use
Antineoplastic Agents therapeutic use
Colorectal Neoplasms drug therapy

Full Text Access

Tools